8-K

                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549


                            FORM 8-K


                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the

                 Securities Exchange Act of 1934

 Date of Report (Date of earliest event reported) June 10, 2003


                 COMPETITIVE TECHNOLOGIES, INC.
     (Exact name of registrant as specified in its charter)



Delaware                 1-8696                   36-2664428
(State or other          (Commission File         (IRS Employer
jurisdiction             Number)                  Identification No.
of incorporation)




1960 Bronson Road, Fairfield, Connecticut         06824
(Address of principal executive offices)         (Zip Code)



Registrant's  telephone number, including area code   (203)  255-6044



Item 9.  Regulation FD Disclosure.

     On June 10, 2003, Competitive Technologies, Inc. (CTT)
announced it fiscal results for the quarter ended April 30, 2003.
A copy of CTT's press release is attached hereto as Exhibit 99.1.

     In accordance with SEC Release Numbers 33-8216 and 34-47583,
the information in this Form 8-K and the attached exhibit is
being furnished under Item 9 rather than under Item 12 and is not
deemed to be "filed" for purposes of the Securities Exchange Act
of 1934, as amended.




                           Signatures


      Pursuant to the requirements of the Securities Exchange Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


                                   COMPETITIVE TECHNOLOGIES, INC.
                                   Registrant


Date:   June  10,  2003               /s/  Frank R. McPike, Jr.
                                      By:  Frank R. McPike, Jr.
                                           Executive Vice President,
                                           Chief Financial Officer and
                                           Authorized Signer


Exhibit Index

     99.1 Press release dated June 10, 2003.            3-5

EX-99.1

                                                         Exhibit 99.1

COMPETITIVE
TECHNOLOGIES
Unlocking the Potential of Innovation

For Immediate Release:


                  COMPETITIVE TECHNOLOGIES REPORTS
                  THIRD QUARTER FISCAL 2003 RESULTS

Fairfield, CT - (June 10, 2003) - Competitive Technologies, Inc.
(AMEX: CTT) announced today its fiscal results for the three and nine
months ended April 30, 2003 showing revenue increases more than
offsetting revenue declines from expiring licenses.

For the first nine months of fiscal 2003 increases in royalties from
homocysteine and Ethyol technologies more than offset declines in
royalties from gallium arsenide and vitamin B12, resulting in
revenues 7% ahead of the prior year.  Revenues for the nine months
ended April 30, 2003 were $1.87 million, compared with $1.75 million
in the nine months ended April 30, 2002.  The increase is primarily
driven by homocysteine assay royalties now being paid by LabCorp and
other major clinical laboratories as CTT continues its aggressive
homocysteine licensing campaign, and from Ethyol royalties.  Revenues
for the third quarter of fiscal 2003 increased 20% to $659,000
compared with $547,000 in the third quarter of fiscal 2002.

The net loss for the nine months ended April 30, 2003 was $1.18
million, compared with a net loss of $3.24 million for the nine
months ended April 30, 2002.  Company performance improved by $2.06
million.  The 64% loss reduction was primarily due to a $910,000
improvement in operating results, this year's reversal of about $1.58
million of patent enforcement expense recorded in prior fiscal years
partially offset by a $944,000 write-down on the NTRU investment, and
last year's $519,000 write off of the loan to E. L. Specialists.  The
net loss for the third quarter of fiscal 2003 was $546,000 compared
with a net loss of $1.03 million for the third quarter of fiscal
2002.  Company performance improved by $486,000.

John B. Nano, President and CEO of CTT said, "We are executing our
strategy and are achieving revenue increases and performance
improvements.  Our strategy is working as it reverses prior years'
declining revenues and declining profits.  The results are still
unacceptable by any measure.  However, we have made progress with our
strategic focus on achieving profitable growth to build shareholder
value."

CTT's performance profile continues to improve.  The company's
enhanced marketing and technology commercialization program and sales
team have targeted specific sales and revenue opportunities creating
new alliances and relationships.  CTT has significantly broadened
both its customer and client technology solution network, including
new agreements with The Texas A & M University System and the
University of South Carolina Research Foundation, two new automotive
safety systems, and continued progress in collecting homocysteine
assay royalties.  CTT's strategic alliance with the Korean Technology
Transfer Center for technology distribution and sourcing in the
expanding Korean market has shown substantial progress.

Working capital at April 30, 2003 of $1.18 million was 4% ahead of
working capital at July 31, 2002 of $1.14 million.  The $600,000
received from the sale of a portion of CTT's expected award in the
patent infringement judgment against Wyeth (NYSE: WYE) will be
included in financial results for the fourth quarter of fiscal 2003.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, is a full service
technology transfer and licensing provider focused on the technology
needs of its customers and transforming those requirements into
commercially viable solutions.  CTT is a global leader in
identifying, developing and commercializing innovative technologies
in life, digital, nano, and physical sciences developed by
universities, companies and inventors.  The global market for
technology transfer services is estimated at $150 billion annually.
CTT maximizes the value of intellectual assets for the benefit of its
customers, clients and shareholders.  Visit CTT's website:
http://www.competitivetech.net

Statements about the Company's future expectations, including
development and regulatory plans, and all other statements in this
document other than historical facts are "forward-looking statements"
within the meaning of applicable Federal Securities Laws and are not
guarantees of future performance.  These statements involve risks and
uncertainties, including those set forth in Item 1 of the Company's
most recent Form 10-K and in CTT's other filings with the SEC, and
are subject to change at any time.  The Company's actual results
could differ materially from these forward-looking statements.  The
Company undertakes no obligation to update publicly any forward-
looking statement.

Direct inquiries to:

Johnnie D. Johnson
Strategic IR, Inc.            E-mail: jdjohnson@strategic-ir.com
Tel. (212) 754-6565
Fax (212) 754-4333            E-mail: ctt@competitivetech.net

                   COMPETITIVE TECHNOLOGIES, INC.
                          AND SUBSIDIARIES
            CONDENSED CONSOLIDATED RESULTS OF OPERATIONS
                (Thousands, except per share amounts)
                             (Unaudited)

                          Third Quarter ended     Nine Months ended
                              April 30,               April 30,
                           2003        2002        2003       2002
  Revenues              $     659   $     547   $   1,874  $   1,754
  Operating expenses
    Patent enforcement
      expenses, net of
      reimbursements          194         602         347      1,787
    Personnel and other
      direct expenses
      relating to
      revenue                 707         543       2,118      1,588
    General and
      administrative
      expenses                308         420       1,248      1,128
  Total operating
    expenses                1,209       1,565       3,713      4,503
  Operating loss        $    (550)  $  (1,017)  $  (1,839) $  (2,749)

  Reversal of accounts
    payable exchanged
    for contingent note
    payable             $      --   $      --   $   1,583  $      --
  Impairment losses on:
    Loans to E. L.
      Specialists, Inc. $      --   $      --   $      --  $    (519)
    Investment in NTRU
      Cryptosystems,
      Inc.              $      --   $      --   $    (944) $      --

  Net loss              $    (546)  $  (1,032)  $  (1,177) $  (3,238)

  Net loss per share
    Basic and diluted   $   (0.09)  $   (0.17)  $   (0.19) $   (0.53)

  Weighted average
    number of common
    shares outstanding
      Basic and diluted     6,201       6,154       6,176      6,146

  OTHER FINANCIAL DATA                           At April    At July
                                                 30, 2003   31, 2002
    Cash, cash
      equivalents and
      short-term
      investments                               $   1,538  $   2,887
    Royalties
      receivable                                $     807  $   1,159
    Total current
      assets                                    $   2,754  $   4,548
    Total assets                                $   3,498  $   6,400

    Royalties payable                           $     966  $   1,308
    Total current
      liabilities                               $   1,570  $   3,407
    Shareholders'
      equity                                    $   1,928  $   2,993